Literature DB >> 1347281

Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis?

P Burra1, S G Hubscher, J Shaw, E Elias, D H Adams.   

Abstract

Alcoholic hepatitis is characterised histologically by an intense inflammatory cell infiltrate made up predominantly of neutrophils but including other cell types, particularly lymphocytes. Leukocyte cytotoxicity requires cell adhesion, which is mediated via receptors on the leukocyte surface including leukocyte function associated antigen-1 (LFA-1) which binds to the ligand intercellular adhesion molecule-1 (ICAM-1) on the target cell. The distribution of ICAM-1 and LFA-1 expression in liver biopsy specimens from patients with alcoholic liver disease was examined to ascertain whether this pathway of leukocyte adhesion is involved in the tissue damage of alcoholic hepatitis. Specimens were stained for ICAM-1 and LFA-1 by a three step immunoalkaline-phosphatase method using monoclonal antibodies against ICAM-1 and LFA-1. LFA-1 staining on portal tract inflammatory cells and parenchymal inflammatory cells and ICAM-1 staining on liver components were examined. ICAM-1 expression on hepatocytes was significantly greater in alcoholic hepatitis compared with fatty liver (p less than 0.001) and normal controls (p less than 0.01). ICAM-1 expression correlated with the histological degree of hepatocellular damage (tau = 0.79; p = 0.0005) and parenchymal inflammation (tau = 0.65; p less than 0.001, and with LFA-1 expression on parenchymal leukocytes (tau = 0.63; p = 0.01). The ICAM-1/LFA-1 pathway may therefore be involved in leukocyte mediated tissue damage during alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347281      PMCID: PMC1373943          DOI: 10.1136/gut.33.2.268

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

2.  Leucocyte adhesion to cells in immune and inflammatory responses.

Authors:  M Patarroyo; M W Makgoba
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

Authors:  M L Dustin; R Rothlein; A K Bhan; C A Dinarello; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  D H Adams; S G Hubscher; J Shaw; G D Johnson; C Babbs; R Rothlein; J M Neuberger
Journal:  Hepatology       Date:  1991-09       Impact factor: 17.425

5.  Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.

Authors:  J Sanchez-Tapias; H C Thomas; S Sherlock
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

6.  Increased tumor necrosis factor production by monocytes in alcoholic hepatitis.

Authors:  C J McClain; D A Cohen
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

7.  Serum interleukin-1 (IL-1) activity in alcoholic hepatitis.

Authors:  C J McClain; D A Cohen; C A Dinarello; J G Cannon; S I Shedlofsky; A M Kaplan
Journal:  Life Sci       Date:  1986-10-20       Impact factor: 5.037

8.  Lymphocyte cytotoxicity in alcoholic hepatitis.

Authors:  S Kakumu; C M Leevy
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

Review 9.  Endotoxin, reticuloendothelial function, and liver injury.

Authors:  J P Nolan
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

10.  Immunohistochemical study of adhesion molecules in liver inflammation.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Hepatology       Date:  1990-07       Impact factor: 17.425

View more
  8 in total

1.  Soluble adhesion molecules in immune mediated liver disease.

Authors:  K J Simpson; P C Hayes
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 2.  Fat: a matter of disturbance for the immune system.

Authors:  Alessandro Federico; Elena D'Aiuto; Francesco Borriello; Giusi Barra; Antonietta Gerarda Gravina; Marco Romano; Raffaele De Palma
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

3.  Immunohistochemical detection of tumor necrosis factor-alpha, other cytokines and adhesion molecules in human livers with alcoholic hepatitis.

Authors:  W Ohlinger; H P Dinges; K Zatloukal; S Mair; F Gollowitsch; H Denk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 4.  Is liver biopsy necessary in the management of alcoholic hepatitis?

Authors:  Ashwin D Dhanda; Peter L Collins; C Anne McCune
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  Coexpression of intercellular adhesion molecule-1 and class I major histocompatibility complex antigens on hepatocyte membrane in chronic viral hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

6.  An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells.

Authors:  Sumera Karim; Evaggelia Liaskou; Samuel Hadley; Janine Youster; Jeff Faint; David H Adams; Patricia F Lalor
Journal:  Toxicol Sci       Date:  2013-01-08       Impact factor: 4.849

7.  Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.

Authors:  Kyung-Hyun Kim; Hyun-Jung Sung; Woo-Ram Lee; Hyun-Jin An; Jung-Yeon Kim; Sok Cheon Pak; Sang-Mi Han; Kwan-Kyu Park
Journal:  Toxins (Basel)       Date:  2015-08-25       Impact factor: 4.546

8.  Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis.

Authors:  Sidsel Støy; Thomas Damgaard Sandahl; Anne Louise Hansen; Bent Deleuran; Thomas Vorup-Jensen; Hendrik Vilstrup; Tue Wenzel Kragstrup
Journal:  Clin Transl Gastroenterol       Date:  2018-06-15       Impact factor: 4.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.